Y

YSP Southeast Asia Holding Bhd
KLSE:YSPSAH

Watchlist Manager
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Watchlist
Price: 2.3 MYR
Market Cap: 326.2m MYR
Have any thoughts about
YSP Southeast Asia Holding Bhd?
Write Note

YSP Southeast Asia Holding Bhd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

YSP Southeast Asia Holding Bhd
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Cash Equivalents
myr139.2m
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
9%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Apex Healthcare Bhd
KLSE:AHEALTH
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Cash Equivalents
myr260.4m
CAGR 3-Years
33%
CAGR 5-Years
23%
CAGR 10-Years
32%
K
Kotra Industries Bhd
KLSE:KOTRA
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

YSP Southeast Asia Holding Bhd
Glance View

Market Cap
326.2m MYR
Industry
Pharmaceuticals

Y.S.P.Southeast Asia Holding Bhd. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2004-01-12. Southeast Asia Holding Bhd. is a Malaysia-based investment holding company that is primarily engaged in the provision of management services. The Company’s segments include Manufacturing, Trading and Investment holding. The Manufacturing segment is engaged in manufacturing of pharmaceutical products. The Trading segment is involved in import, export and trading of various kinds of pharmaceutical, traditional herbal and veterinary products. The Investment holding segment is engaged in investment holding. Its subsidiaries include Y.S.P. (Cambodia) Pte. Ltd., which is engaged in providing management services, such as product registration trademark registration and national marketing and trading in all kinds of pharmaceutical products, and Alpha Active Industries Sdn. Bhd., which is engaged in the manufacture of biotechnology products and health products.

YSPSAH Intrinsic Value
2.88 MYR
Undervaluation 20%
Intrinsic Value
Price
Y

See Also

What is YSP Southeast Asia Holding Bhd's Cash Equivalents?
Cash Equivalents
139.2m MYR

Based on the financial report for Jun 30, 2024, YSP Southeast Asia Holding Bhd's Cash Equivalents amounts to 139.2m MYR.

What is YSP Southeast Asia Holding Bhd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
9%

Over the last year, the Cash Equivalents growth was 2%. The average annual Cash Equivalents growth rates for YSP Southeast Asia Holding Bhd have been 6% over the past three years , 9% over the past five years , and 9% over the past ten years .

Back to Top